# Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study

> **NCT06274541** · — · COMPLETED · sponsor: **Cancer Trials Ireland** · enrollment: 200 (actual)

## Conditions studied

- Serous Ovarian Tumor
- Endometrioid Carcinoma Ovary
- Fallopian Tube Cancer
- Primary Peritoneal Carcinoma

## Interventions

- **GENETIC:** Somatic and Germline BRCA1/2 Testing

## Key facts

- **NCT ID:** NCT06274541
- **Lead sponsor:** Cancer Trials Ireland
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-22
- **Primary completion:** 2025-12-17
- **Final completion:** 2026-03-12
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06274541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06274541, "Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06274541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*